Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities.
In order to gain some insight into the cause of acute regional toxicity after isolated perfusion using melphalan, 15 patient-related and perfusion-technique-related factors were tested in a logistic regression model. Acute toxicity was graded according to Wieberdink's grading system. In a group of 425 patients, 362 (85%) encountered no or slight toxicity with a grade I or II reaction, and 63 (15%) patients encountered more severe toxicity with a grade III, IV, or V reaction. Most patients were treated with a standard dose of 10 or 13 mg melphalan per liter of perfused tissue for leg and arm perfusions, respectively. Factors associated with a more severe toxicity reaction proved to be tissue temperatures of 40 degrees C or higher, female gender, a deterioration of the gas values of the venous perfusate during perfusion, and perfusion at a proximal level of isolation. Consideration of these prognostic factors may lead to a further decrease of acute regional toxicity in perfusion.
Klaase
J M
JM
Department of Surgery, The Netherlands Cancer Institute, Amsterdam.
Kroon
B B
BB
van Geel
B N
BN
Eggermont
A M
AM
Franklin
H R
HR
Hart
G A
GA
D000328:Adult; D000704:Analysis of Variance; D001132:Arm; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects* / Q000379:methods; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects; D007866:Leg; D016015:Logistic Models; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects*; D008875:Middle Aged; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy*
D008558:Melphalan